A Trial to Evaluate the Safety, Tolerability and Preliminary Efficacy of NCR201 in the Treatment of Subjects With Parkinson's Disease
Phase 1
Not yet recruiting
- Conditions
- Parkinson Disease
- Interventions
- Drug: Allogeneic dopaminergic neural precursor cell(NCR201)
- First Posted Date
- 2025-05-18
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Nuwacell Biotechnologies Co., Ltd.
- Target Recruit Count
- 48
- Registration Number
- NCT06978920
- Locations
- 🇨🇳
The First Affiliated Hospital of USTC, Hefei, Anhui, China
A Trial to Evaluate the Safety and Efficacy of NCR102 in Subjects With aGVHD
Phase 1
Not yet recruiting
- Conditions
- Acute Graft-versus-Host Disease
- Interventions
- Biological: NCR102 injection
- First Posted Date
- 2025-04-23
- Last Posted Date
- 2025-04-23
- Lead Sponsor
- Nuwacell Biotechnologies Co., Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT06941350
A Trial to Evaluate the Safety, Tolerability and Preliminary Efficacy of NCR101 in the Treatment of Subjects With Interstitial Lung Disease
Phase 1
Not yet recruiting
- Conditions
- Interstitial Lung Disease (ILD)
- Interventions
- First Posted Date
- 2025-02-13
- Last Posted Date
- 2025-02-13
- Lead Sponsor
- Nuwacell Biotechnologies Co., Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT06825169
A Study of NCR100 Injection for the Treatment of Knee Osteoarthritis（ KOA）
Phase 1
Not yet recruiting
- Conditions
- Knee Osteoarthritis
- Interventions
- Other: 0.9% Normal saline
- First Posted Date
- 2024-12-18
- Last Posted Date
- 2024-12-18
- Lead Sponsor
- Nuwacell Biotechnologies Co., Ltd.
- Target Recruit Count
- 162
- Registration Number
- NCT06741098
A Trial to Evaluate the Safety and Efficacy of NCR300 in Preventing Recurrence of Acute Myeloid Leukemia（AML) After Transplantation
Phase 1
Not yet recruiting
- Conditions
- Acute Myeloid Leukemia
- Interventions
- Biological: NCR300 injection
- First Posted Date
- 2024-06-04
- Last Posted Date
- 2024-06-04
- Lead Sponsor
- Nuwacell Biotechnologies Co., Ltd.
- Target Recruit Count
- 15
- Registration Number
- NCT06441084
A Trial to Evaluate the Safety and Preliminary Efficacy of iNK in the Treatment of Subjects With Solid Tumor
Not Applicable
Not yet recruiting
- Conditions
- Solid Tumor
- Interventions
- Biological: iNK Injection
- First Posted Date
- 2024-02-07
- Last Posted Date
- 2024-02-07
- Lead Sponsor
- Nuwacell Biotechnologies Co., Ltd.
- Target Recruit Count
- 50
- Registration Number
- NCT06245018
A Trial to Evaluate the Safety, Tolerability, and Efficacy of NCR100 Injection in the Treatment of Subjects With KOA
Phase 1
Not yet recruiting
- Conditions
- Knee Osteoarthritis
- Interventions
- Biological: NCR100 injection
- First Posted Date
- 2023-09-22
- Last Posted Date
- 2024-01-19
- Lead Sponsor
- Nuwacell Biotechnologies Co., Ltd.
- Target Recruit Count
- 12
- Registration Number
- NCT06049342
A Trial to Evaluate the Safety and Efficacy of NK Cells in Subjects With Myelodysplastic Syndromes
Early Phase 1
Not yet recruiting
- Conditions
- Relapsed / Refractory Myelodysplastic Syndromes
- Interventions
- First Posted Date
- 2022-05-12
- Last Posted Date
- 2022-05-12
- Lead Sponsor
- Nuwacell Biotechnologies Co., Ltd.
- Target Recruit Count
- 15
- Registration Number
- NCT05371730
© Copyright 2025. All Rights Reserved by MedPath